CHG-2024-0241
New Dosage Strength for Kcluximab. Container Closure Change for Kcluximab — major revision. Impacts 7 markets and 1 variations.
Change Number
CHG-2024-0241
Type
New Dosage Strength
Product
Status
Draft
Owner
James O'Brien
Initiated
2023-04-13
Description
Container Closure Change for Kcluximab — major revision
Impacted Markets (7)
CN — ChinaCH — SwitzerlandDE — GermanyIT — ItalyTR — TurkeyBE — BelgiumDK — Denmark
Impacted Modules
3.2.P5.3.5
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|